Formation of supramolecular structures of alkylamides from Echinacea -: implications for cannabinoid type-2 receptor (CB2) interactions in vitro

被引：0
|
作者：
Roduner, S.
Bisson, W.
Altmann, K. H.
Gertsch, J.
机构：
[1] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland
[2] Scripps Res Inst, La Jolla, CA 92037 USA
来源：
PLANTA MEDICA | 2006年 / 72卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q94 [植物学];
学科分类号：
071001 ;
摘要：
P099
引用
收藏
页码：1013 / 1013
页数：1
相关论文
共 50 条
  • [1] The central cannabinoid receptor type-2 (CB2) and chronic pain
    Shang, Yuchao
    Tang, Yuying
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2017, 127 (09) : 812 - 823
  • [2] Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential
    Gasperi, Valeria
    Guzzo, Tatiana
    Topai, Alessandra
    Gambacorta, Nicola
    Ciriaco, Fulvio
    Nicolotti, Orazio
    Maccarrone, Mauro
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (12) : 1420 - 1457
  • [3] Echinacea alkylamides modulate TNF-α gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways
    Gertsch, J
    Schoop, R
    Kuenzle, U
    Suter, A
    FEBS LETTERS, 2004, 577 (03) : 563 - 569
  • [4] In vitro pharmacological characterization of cannabinoid receptor CB2 agonists
    Wang, Yung-Chih
    Lu, Mark
    Riviere, Pierre
    Croston, Glenn
    INFLAMMATION RESEARCH, 2006, 55 : S121 - S121
  • [5] Cannabinoid Receptor CB2 Structure and CB2/Gi Signaling Mechanisms
    Xing, Changrui
    Zhang, Cheng
    Xie, Xiang-Qun
    FASEB JOURNAL, 2019, 33
  • [6] Functional Selectivity in CB2 Cannabinoid Receptor Signaling and Regulation: Implications for the Therapeutic Potential of CB2 Ligands
    Atwood, Brady K.
    Wager-Miller, James
    Haskins, Christopher
    Straiker, Alex
    Mackie, Ken
    MOLECULAR PHARMACOLOGY, 2012, 81 (02) : 250 - 263
  • [7] Review -: New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptors
    Gertsch, Juerg
    Raduner, Stefan
    Altmann, Karl-Heinz
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2006, 26 (5-6) : 709 - 730
  • [8] CB2: a cannabinoid receptor with an identity crisis
    Atwood, Brady K.
    Mackie, Ken
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (03) : 467 - 479
  • [9] Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
    Han, Sangdon
    Thatte, Jayant
    Buzard, Daniel J.
    Jones, Robert M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (21) : 8224 - 8256
  • [10] CB2 cannabinoid receptor mediation of antinociception
    Ibrahim, Mohab M.
    Rude, Megan L.
    Stagg, Nicola J.
    Mata, Heriberto P.
    Lai, Josephine
    Vanderah, Todd W.
    Porreca, Frank
    Buckley, Nancy E.
    Makriyannis, Alexandros
    Malan, T. Philip, Jr.
    PAIN, 2006, 122 (1-2) : 36 - 42
12345